Compare
Bioforce Nanosciences Holdings, Inc. vs Lifeloc Technologies, Inc vs Astrotech Corp vs Precipio, Inc.
| Latest fiscal year | Bioforce Nanosciences Holdings, Inc. BFNH | Lifeloc Technologies, Inc LCTC | Astrotech Corp ASTC | Precipio, Inc. PRPO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-06-30 | 2025-12-31 |
| Revenue | n/a | $9.03M | $913.0K | $24.05M |
| Revenue growth (YoY) | n/a | +5.7% | -13.0% | +29.8% |
| Gross margin | n/a | 40.3% | 23.8% | 44.5% |
| Operating margin | n/a | -13.6% | n/m | -5.0% |
| Net margin | n/a | -27.4% | n/m | -1.5% |
| Net income | -$1.29M | -$2.47M | -$14.43M | -$363.0K |
| EPS (Diluted) | -$0.04 | -$0.90 | n/a | -$0.23 |
| Operating cash flow | -$65.2K | -$499.3K | -$13.45M | $685.0K |
| Free cash flow | n/a | -$962.1K | -$14.33M | $359.0K |
| Cash & equivalents | $786 | n/a | $8.39M | $2.65M |
| Total assets | $786 | $6.69M | $20.51M | $21.32M |
| Total liabilities | $619.3K | $2.58M | $4.33M | $6.76M |
| Shareholders' equity | -$618.5K | $4.10M | $16.17M | $14.56M |
| Return on year-end equity | n/a | -60.2% | -89.2% | -2.5% |
| Shares outstanding | 33.52M | 2.75M | 2.00M | 1.78M |
Revenue, most recent five fiscal years
| Fiscal year | Bioforce Nanosciences Holdings, Inc. | Lifeloc Technologies, Inc | Astrotech Corp | Precipio, Inc. |
|---|---|---|---|---|
| Latest | $17.8K Ended 2019-12-31 | $9.03M Ended 2025-12-31 | $913.0K Ended 2026-06-30 | $24.05M Ended 2025-12-31 |
| 1 year earlier | $16.3K Ended 2018-12-31 | $8.54M Ended 2024-12-31 | $1.05M Ended 2025-06-30 | $18.53M Ended 2024-12-31 |
| 2 years earlier | $4.5K Ended 2017-12-31 | $9.33M Ended 2023-12-31 | $1.66M Ended 2024-06-30 | $15.20M Ended 2023-12-31 |
| 3 years earlier | n/a | $8.48M Ended 2022-12-31 | $750.0K Ended 2023-06-30 | $9.41M Ended 2022-12-31 |
| 4 years earlier | n/a | $7.05M Ended 2021-12-31 | $869.0K Ended 2022-06-30 | $8.85M Ended 2021-12-31 |